Literature DB >> 26392288

Homozygosity for a factor XII mutation in one female and one male patient with hereditary angio-oedema.

A S Grumach1, C Stieber2,3, C L Veronez4, N Cagini4, R N Constantino-Silva1, E Cordeiro1, M M Nöthen2,3, J B Pesquero4, S Cichon2,3,5.   

Abstract

Hereditary angio-oedema (HAE) with normal C1 inhibitor is associated with heterozygous mutations in the factor XII gene (FXII-HAE). We report two Brazilian FXII-HAE families segregating the mutation c.983 C>A (p.Thr328Lys). In each family, one patient with a homozygous mutation was found. The homozygous female patient in family 1 displayed a severe phenotype. However, this falls within the clinical phenotype spectrum reported for heterozygous female mutation carriers. The homozygous male patient in family 2 also showed a severe phenotype. This finding is intriguing, as to our knowledge, it is the first such report for a male FXII-HAE mutation carrier. In the rare instances in which male mutation carriers are affected, a mild phenotype is typical. The present findings therefore suggest that homozygous FXII-HAE mutation status leads to a severe phenotype in females and males, and to an increased risk of manifest symptoms in the latter.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  factor XII; hereditary angio-oedema; homozygosity

Mesh:

Substances:

Year:  2015        PMID: 26392288     DOI: 10.1111/all.12769

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  4 in total

1.  The FXII c.-4T>C Polymorphism as a Disease Modifier in Patients With Hereditary Angioedema Due to the FXII p.Thr328Lys Variant.

Authors:  Fernando Corvillo; María Eugenia de la Morena-Barrio; Carmen Marcos-Bravo; Margarita López-Trascasa; Vicente Vicente; Jonas Emsley; Teresa Caballero; Javier Corral; Alberto López-Lera
Journal:  Front Genet       Date:  2020-09-10       Impact factor: 4.599

Review 2.  Leveraging Genetics for Hereditary Angioedema: A Road Map to Precision Medicine.

Authors:  Anastasios E Germenis; Matija Rijavec; Camila Lopes Veronez
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-28       Impact factor: 8.667

Review 3.  Bradykinin: Inflammatory Product of the Coagulation System.

Authors:  Zonne Hofman; Steven de Maat; C Erik Hack; Coen Maas
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

4.  Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.

Authors:  Konrad Bork; Thomas Machnig; Karin Wulff; Guenther Witzke; Subhransu Prusty; Jochen Hardt
Journal:  Orphanet J Rare Dis       Date:  2020-10-15       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.